Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm
Johanne Poisson, … , Chantal M. Boulanger, Pierre-Emmanuel Rautou
Johanne Poisson, … , Chantal M. Boulanger, Pierre-Emmanuel Rautou
Published February 11, 2020
Citation Information: J Clin Invest. 2020;130(5):2630-2643. https://doi.org/10.1172/JCI124566.
View: Text | PDF
Research Article Cardiology Hematology

Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm

  • Text
  • PDF
Abstract

Arterial cardiovascular events are the leading cause of death in patients with JAK2V617F myeloproliferative neoplasms (MPNs). However, their mechanisms are poorly understood. The high prevalence of myocardial infarction without significant coronary stenosis or atherosclerosis in patients with MPNs suggests that vascular function is altered. The consequences of JAK2V617F mutation on vascular reactivity are unknown. We observe here increased responses to vasoconstrictors in arteries from Jak2V617F mice resulting from a disturbed endothelial NO pathway and increased endothelial oxidative stress. This response was reproduced in WT mice by circulating microvesicles isolated from patients carrying JAK2V617F and by erythrocyte-derived microvesicles from transgenic mice. Microvesicles of other cellular origins had no effect. This effect was observed ex vivo on isolated aortas, but also in vivo on femoral arteries. Proteomic analysis of microvesicles derived from JAK2V617F erythrocytes identified increased expression of myeloperoxidase as the likely mechanism accounting for their effect. Myeloperoxidase inhibition in microvesicles derived from JAK2V617F erythrocytes suppressed their effect on oxidative stress. Antioxidants such as simvastatin and N-acetyl cysteine improved arterial dysfunction in Jak2V617F mice. In conclusion, JAK2V617F MPNs are characterized by exacerbated vasoconstrictor responses resulting from increased endothelial oxidative stress caused by circulating erythrocyte-derived microvesicles. Simvastatin appears to be a promising therapeutic strategy in this setting.

Authors

Johanne Poisson, Marion Tanguy, Hortense Davy, Fatoumata Camara, Marie-Belle El Mdawar, Marouane Kheloufi, Tracy Dagher, Cécile Devue, Juliette Lasselin, Aurélie Plessier, Salma Merchant, Olivier Blanc-Brude, Michèle Souyri, Nathalie Mougenot, Florent Dingli, Damarys Loew, Stephane N. Hatem, Chloé James, Jean-Luc Villeval, Chantal M. Boulanger, Pierre-Emmanuel Rautou

×

Figure 5

MPO carried by erythrocyte-derived microvesicles from Jak2V617F mice is responsible for increased endothelial oxidative stress.

Options: View larger image (or click on image) Download as PowerPoint
MPO carried by erythrocyte-derived microvesicles from Jak2V617F mice is ...
(A) Volcano plot obtained by using quantitative label-free mass spectrometry analysis of proteins isolated from microvesicles derived from JAK2V617F (n = 6) and JAK2WT (n = 4) erythrocytes (ratio JAK2V617F/JAK2WT); only proteins involved in cellular oxidant detoxification (GO 0098869) and ROS metabolic process (GO 0072593) are presented (red line corresponds to P = 0.05). Representative image of GSTT1 (B) and MPO (D) Western blots performed on erythrocyte-derived microvesicles, with respective quantification (C and E) (JAK2WT erythrocyte microvesicles, n = 11; JAK2V617F erythrocyte microvesicles, n = 11). (F) Quantification of ROS generation (red surface) per endothelial cell (HUVEC) after exposition of erythrocyte-derived microvesicles from control mice (Jak2WT) (n = 4) and Jak2V617F HC-EC mice and without (red, n = 4) and with (n = 4) preincubation with an MPOi (PF06281355, 5 mol/L). (G) Representative images of HUVEC staining with CellROX (red fluorogenic probes for ROS generation) and DAPI (nuclei in blue). Scale bars: 10 μm. *P < 0.05, ***P < 0.001. Quantitative data are expressed as median with IQR and compared using the Mann-Whitney U test and Kruskal-Wallis test for multiple comparisons. CY24A, cytochrome b-245 light chain; CY24B, cytochrome b-245 heavy chain.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts